Host: |
Rabbit |
Applications: |
IHC/IF |
Reactivity: |
Human/Mouse/Rat |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-Centrosomal protein of 295 kDa (208-258 aa) is suitable for use in Immunohistochemistry and Immunofluorescence research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
IHC-P 1:50-200IF 1:50-200 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CEP295 |
Gene ID: |
85459 |
Uniprot ID: |
CE295_HUMAN |
Immunogen Region: |
208-258 aa |
Specificity: |
This antibody detects endogenous levels of K1731 at Human/Mouse/Rat |
Immunogen: |
Synthesized peptide derived from the human K1731 at the amino acid range 208-258 |
Protein Name | Centrosomal Protein Of 295 Kda |
Cellular Localisation | CytoplasmCytoskeletonMicrotubule Organizing CenterCentrosomeCentrioleSpindleAssociates With Both Of The Converted Centrioles During G1 But Becomes More Enriched At The Newly Formed Daughter (Or Unconverted) Centrioles During SG2And Early M PhasesIn Early S PhaseLocalized At The Procentriolar Microtubule Wall And Enriched At The Proximal Ends Of The Centrioles In Cenpj- And Cep135-Dependent MannerColocalizes With Sass6 And Cep250 ProteinsColocalizes With Cep135 And Cep192 At The CentrosomesAssociates With Interphase Microtubules And Mitotic SpindlesColocalizes With Centriolar Acetylated Tubulin |
Alternative Antibody Names | Anti-Centrosomal Protein Of 295 Kda antibodyAnti-CEP295 antibodyAnti-KIAA1731 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance